e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Different patterns of interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determination of pulmonary hypertension degree in patients with interstitial lung diseases
V. Osipenko, E. Kogan, A. Shechter, O. Kichigina, E. Popova (Moscow, Russian Federation)
Source:
Annual Congress 2010 - Different patterns of interstitial lung disease
Session:
Different patterns of interstitial lung disease
Session type:
Thematic Poster Session
Number:
786
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Osipenko, E. Kogan, A. Shechter, O. Kichigina, E. Popova (Moscow, Russian Federation). Determination of pulmonary hypertension degree in patients with interstitial lung diseases. Eur Respir J 2010; 36: Suppl. 54, 786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Imaging of complicated pneumonia: what is new?
Pulmonary sarcoidosis
Related content which might interest you:
Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Pulmonary hypertension in different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Pulmonary hypertension in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013
Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
The effect of lung diseases on pulmonary hypertension and the effect of pulmonary hypertension on the lung
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018
The frequency of pulmonary embolism in cases with interstitial lung diseases
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008
Patients profile and pulmonary rehabilitation in interstitial lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Pulmonary hypertension in interstitial lung disease: Non-invasive assessment for detection and prognosis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept